$ATR

Prieur Marc sold $477K of ATR

Prieur Marc (Segment President) sold 3,500 shares of APTARGROUP, INC. (ATR) at an average of $136.26 ($136.23–$137.10, $0.48M total) across 2 trades on 2026-08-04.

Original reporting
SEC EDGAR · Prieur Marc
Published Aug 5, 2026, 9:50 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 9:52 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ATR
Neutral
high confidence
Mentioned
$ATR
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ATRNeutralLow
01

Why it matters

Insider open-market sales can modestly affect sentiment, but this filing does not include new guidance, earnings, contracts, or regulatory actions.

02

Market read

Traders may note the insider sale as a small sentiment datapoint, but it is unlikely to drive a durable repricing without additional catalysts.

03

What to watch

No 10b5-1 plan is cited, but the filing does not provide intent, tax context, or whether other insiders are selling/buying around the same window.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-05 after-hours; sale executed 2026-08-04

Background

The article is an SEC Form 4 insider transaction disclosure for AptarGroup, Inc. (ATR).

Company-level read

Ticker impact

$ATRNeutralHigh confidence
Context

Form 4 shows insider Prieur Marc sold about $477K of ATR shares on 2026-08-04 at roughly $136.23 to $137.10 per share.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and typically fades unless repeated or paired with other disclosures.

Evidence & confidence

The filing is a Form 4 transaction detail without accompanying guidance, operational updates, or regulatory/legal developments. Insider sales are common and often not predictive absent additional context.

Market effects

No sector read-through; this is company-specific insider trading disclosure.

None indicated.

None indicated.

Counterpoint

The sale could be for diversification or personal liquidity needs, especially given the modest dollar value relative to a large-cap and the lack of any accompanying negative company news.

Key entities

  • AptarGroup, Inc.

    Company whose insider transaction is disclosed on Form 4.

  • Prieur Marc

    Segment President who sold shares in open-market transactions.

Related articles

$ATRMedAI 8/10

Aptar (ATR) Q2 2026 Earnings Call Transcript

AptarGroup (ATR) reported Q2 2026 total sales of $1.03B, up 6% reported, with adjusted EPS of $1.42 above guidance. Adjusted EBITDA was $213M, down 3%, and margins fell due to mix and operational issues in beauty. Pharma core sales grew 8% excluding emergency medicine destocking. Net debt was $1.2B, leverage 1.49x, and Q3 adjusted EPS guidance is $1.45 to $1.53.

$ATRMed

APTARGROUP, INC. (ATR): Results of Operations and Financial Condition

APTARGROUP, INC. (ATR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 atr-20260630x8kexx991.htm EX-99.1 Document Exhibit 99.1 Aptar Reports Second Quarter 2026 Results Crystal Lake, Illinois, July 30, 2026 -- AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing,